1 All‐cause mortality |
5 |
2833 |
Risk Ratio (M‐H, Random, 95% CI) |
1.11 [0.41, 3.01] |
2 Incidence of type 2 diabetes |
12 |
3632 |
Risk Ratio (M‐H, Random, 95% CI) |
0.50 [0.38, 0.65] |
3 Incidence of type 2 diabetes (blinded vs open‐label) |
12 |
3632 |
Risk Ratio (M‐H, Random, 95% CI) |
0.50 [0.38, 0.65] |
3.1 Participants blinded |
2 |
2240 |
Risk Ratio (M‐H, Random, 95% CI) |
0.74 [0.64, 0.86] |
3.2 Open‐label |
10 |
1392 |
Risk Ratio (M‐H, Random, 95% CI) |
0.40 [0.27, 0.59] |
4 Incidence of type 2 diabetes (duration of the intervention) |
12 |
3632 |
Risk Ratio (M‐H, Random, 95% CI) |
0.50 [0.38, 0.65] |
4.1 Duration of the intervention less than 2 years |
4 |
296 |
Risk Ratio (M‐H, Random, 95% CI) |
0.30 [0.14, 0.66] |
4.2 Duration of the intervention 2 years or more |
8 |
3336 |
Risk Ratio (M‐H, Random, 95% CI) |
0.53 [0.40, 0.71] |
5 Incidence of type 2 diabetes (ethnicity) |
12 |
3632 |
Risk Ratio (M‐H, Random, 95% CI) |
0.50 [0.38, 0.65] |
5.1 mainly White |
1 |
2155 |
Risk Ratio (M‐H, Random, 95% CI) |
0.75 [0.65, 0.87] |
5.2 mainly Asian |
10 |
1418 |
Risk Ratio (M‐H, Random, 95% CI) |
0.41 [0.28, 0.59] |
5.3 Other |
1 |
59 |
Risk Ratio (M‐H, Random, 95% CI) |
0.34 [0.01, 8.13] |
6 Non‐serious adverse events |
2 |
285 |
Risk Ratio (M‐H, Random, 95% CI) |
3.86 [0.18, 83.36] |
7 2‐hr glucose values |
13 |
3346 |
Mean Difference (IV, Random, 95% CI) |
‐0.86 [‐1.26, ‐0.46] |
8 2‐hr glucose values (blinded vs open‐label) |
13 |
3346 |
Mean Difference (IV, Random, 95% CI) |
‐0.86 [‐1.26, ‐0.46] |
8.1 Participants blinded |
4 |
2032 |
Mean Difference (IV, Random, 95% CI) |
‐0.26 [‐0.86, 0.33] |
8.2 Open‐label |
9 |
1314 |
Mean Difference (IV, Random, 95% CI) |
‐1.03 [‐1.35, ‐0.71] |
9 2‐hr glucose values (duration of intervention) |
13 |
3346 |
Mean Difference (IV, Random, 95% CI) |
‐0.86 [‐1.26, ‐0.46] |
9.1 Duration of intervention less than 2 years |
4 |
286 |
Mean Difference (IV, Random, 95% CI) |
‐1.37 [‐1.91, ‐0.82] |
9.2 Duration of intervention 2 years or more |
9 |
3060 |
Mean Difference (IV, Random, 95% CI) |
‐0.75 [‐1.18, ‐0.33] |
10 2‐r glucose values (ethnicity) |
13 |
3346 |
Mean Difference (IV, Random, 95% CI) |
‐0.86 [‐1.26, ‐0.46] |
10.1 Mainly White |
1 |
1856 |
Mean Difference (IV, Random, 95% CI) |
0.0 [‐0.17, 0.17] |
10.2 Mainly Asian |
10 |
1384 |
Mean Difference (IV, Random, 95% CI) |
‐1.05 [‐1.35, ‐0.75] |
10.3 Other |
2 |
106 |
Mean Difference (IV, Random, 95% CI) |
0.05 [‐0.69, 0.79] |
11 HbA1c (blinded vs open‐label) |
6 |
2467 |
Mean Difference (IV, Random, 95% CI) |
‐0.08 [‐0.22, 0.05] |
11.1 Participants blinded |
2 |
1926 |
Mean Difference (IV, Random, 95% CI) |
0.0 [‐0.04, 0.04] |
11.2 Open‐label |
4 |
541 |
Mean Difference (IV, Random, 95% CI) |
‐0.35 [‐0.77, 0.08] |
12 HbA1c (duration of intervention) |
6 |
2467 |
Mean Difference (IV, Random, 95% CI) |
‐0.08 [‐0.22, 0.05] |
12.1 Duration of intervention less than 2 years |
3 |
269 |
Mean Difference (IV, Random, 95% CI) |
‐0.15 [‐0.50, 0.21] |
12.2 Duration of intervention 2 years or more |
3 |
2198 |
Mean Difference (IV, Random, 95% CI) |
‐0.26 [‐0.75, 0.22] |
13 HbA1c (ethnicity) |
6 |
2467 |
Mean Difference (IV, Random, 95% CI) |
‐0.08 [‐0.22, 0.05] |
13.1 Mainly White |
1 |
1856 |
Mean Difference (IV, Random, 95% CI) |
0.0 [‐0.04, 0.04] |
13.2 Mainly Asian |
4 |
556 |
Mean Difference (IV, Random, 95% CI) |
‐0.45 [‐0.74, ‐0.16] |
13.3 Other |
1 |
55 |
Mean Difference (IV, Random, 95% CI) |
0.0 [‐0.11, 0.11] |
14 Fasting plasma glucose |
15 |
3546 |
Mean Difference (IV, Random, 95% CI) |
‐0.28 [‐0.42, ‐0.13] |
15 Fasting plasma glucose (blinded vs open‐label) |
15 |
3546 |
Mean Difference (IV, Random, 95% CI) |
‐0.28 [‐0.42, ‐0.13] |
15.1 Participants blinded |
4 |
2037 |
Mean Difference (IV, Random, 95% CI) |
‐0.51 [‐0.94, ‐0.09] |
15.2 Open‐label |
11 |
1509 |
Mean Difference (IV, Random, 95% CI) |
‐0.22 [‐0.42, ‐0.03] |
16 Fasting plasma glucose (duration of the intervention) |
15 |
3546 |
Mean Difference (IV, Random, 95% CI) |
‐0.28 [‐0.42, ‐0.13] |
16.1 Duration of the intervention less than 2 years |
6 |
485 |
Mean Difference (IV, Random, 95% CI) |
‐0.51 [‐0.89, ‐0.13] |
16.2 Duration of the intervention 2 years or more |
9 |
3061 |
Mean Difference (IV, Random, 95% CI) |
‐0.19 [‐0.35, ‐0.02] |
17 Fasting plasma glucose (ethnicity) |
15 |
3546 |
Mean Difference (IV, Random, 95% CI) |
‐0.28 [‐0.42, ‐0.13] |
17.1 Mainly White |
1 |
1861 |
Mean Difference (IV, Random, 95% CI) |
‐0.30 [‐0.39, ‐0.21] |
17.2 Mainly Asian |
11 |
1524 |
Mean Difference (IV, Random, 95% CI) |
‐0.31 [‐0.51, ‐0.11] |
17.3 Other |
3 |
161 |
Mean Difference (IV, Random, 95% CI) |
‐0.14 [‐0.49, 0.22] |